Photo: Hindustan Times
India-Made COVID-19 Vaccines Likely To Get Market Approval With Capped Prices
The two COVID-19 vaccines, Covishield and Covaxin will soon get the regular market approval with capped prices. According to the Drug Controller General of India, the SII and Bharat Biotech urged the DGCI to grant regular market approval for adult population with certain conditions. If approved, vaccines will be available at Rs 275 plus Rs 150 additional charges. Notably, Covaxin and Covishield are available at Rs 1,200 and 780, respectively… read-more
Tags: Covaxin, Covishield vaccine, Bharat biotech, Serum Institute of India, DRUG CONTROLLER GENERAL OF INDIA
Courtesy: Zee News
Photo: The Financial Express
Zydus COVID-19 Vaccine For Children To Launch Shortly In India
The government on June 27 declared that the vaccination process for children aged between 12 to 18 may start by July-end or August as the trials for Zydus Cadila is almost complete. The Zydus Cadila vaccine Zy-CoV-D will soon apply for authorisation for emergency use to the Drugs Controller General of India. The vaccine is asserted to be safe for use in both children and adults.
Tags: Zydus Cadila, Coronavirus Vaccines, DRUG CONTROLLER GENERAL OF INDIA, Emergency Use Authorization
Courtesy: The Times of India
